Filana Therapeutics (FLNA) Other Working Capital Changes (2010 - 2026)
Filana Therapeutics (FLNA) posted quarterly Other Working Capital Changes of -$365000.0 for Q2 2026, up 4.7% year-over-year from -$348616.0 in Q2 2025, and up 57.9% quarter-over-quarter from -$867000.0 in Q1 2026.
Filana Therapeutics (FLNA) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Filana Therapeutics' Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$365000.0 for Q2 2026.
- In Q2 2026, Other Working Capital Changes rose 4.7% year-over-year to -$365000.0; the TTM figure through Jun 2026 stood at -$1.8 million (up 85.52% YoY), while the FY2025 annual figure was -$6.1 million, down 1028.01% from the prior year.
- Other Working Capital Changes for Q2 2026 stood at -$365000.0, up from -$867000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $5.0 million in Q2 2024, with the low at -$5.6 million in Q4 2024.
- The 5-year median for Other Working Capital Changes is -$374000.0 (2025), against an average of -$597444.4.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes jumped 674.59% in 2022, then plunged 946.61% in 2024.
- Filana Therapeutics' Other Working Capital Changes stood at $1.6 million in 2022, then sank by 58.59% to $663000.0 in 2023, then slumped by 946.61% to -$5.6 million in 2024, then soared by 83.04% to -$952000.0 in 2025, then soared by 61.66% to -$365000.0 in 2026.
- Business Quant data shows FLNA's Other Working Capital Changes at -$365000.0 in Q2 2026, -$867000.0 in Q1 2026, and -$952000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Filana Therapeutics | 46.01 Mn | 46.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -365,000.00 |
| Jun 30, 2026 | -365,000.00 |
| Jun 30, 2026 | -365,000.00 |
| Mar 31, 2026 | -867,000.00 |
| Mar 31, 2026 | -867,000.00 |
| Mar 31, 2026 | -867,000.00 |
| Dec 31, 2025 | -952,000.00 |
| Dec 31, 2025 | -952,000.00 |
| Dec 31, 2025 | -952,000.00 |
| Sep 30, 2025 | 390,000.00 |
| Sep 30, 2025 | 390,000.00 |
| Sep 30, 2025 | 390,000.00 |
| Jun 30, 2025 | -383,000.00 |
| Jun 30, 2025 | -383,000.00 |
| Jun 30, 2025 | -383,000.00 |
| Mar 31, 2025 | -5.14 Mn |
| Mar 31, 2025 | -5.14 Mn |
| Mar 31, 2025 | -5.14 Mn |
| Dec 31, 2024 | -5.61 Mn |
| Dec 31, 2024 | -5.61 Mn |